Target intelligence / Profile preview

T-cell receptor recognizing poliovirus-derived peptides presented on MHC class II (Poliovirus-specific TCR (MHC-II restricted))

Target
Poliovirus-specific TCR (MHC-II restricted)
Molecular classification
Receptor, T-cell receptor complex, Antigen-recognition molecule
01

Overview

T-cell receptors (TCRs) recognizing poliovirus-derived peptides presented on MHC class II molecules are specialized protein complexes found on the surface of CD4+ T helper cells. These receptors play a pivotal role in the adaptive immune response by identifying specific viral fragments, typically from the poliovirus capsid proteins VP1, VP2, VP3, and VP4, that are displayed by antigen-presenting cells (PMID: 28416511). Upon binding to the peptide-MHC II complex, the TCR initiates intracellular signaling that leads to T-cell activation, proliferation, and the secretion of pro-inflammatory cytokines such as interferon-gamma (PMID: 16148104). This process is essential for providing help to B cells for high-affinity neutralizing antibody production and for establishing long-lived memory T cells. These TCRs are the primary cellular targets of poliovirus vaccines, including the Inactivated Poliovirus Vaccine (IPV) and the Oral Poliovirus Vaccine (OPV), which aim to elicit a robust and specific T-cell repertoire (PMID: 30206155). Understanding the diversity and specificity of these TCRs is crucial for monitoring vaccine-induced immunity and for the development of new vaccine strategies to combat vaccine-derived poliovirus outbreaks. Furthermore, these receptors serve as key indicators in research focusing on the cellular correlates of protection against poliomyelitis. Therapeutic challenges include the potential for viral mutations to escape TCR recognition and the need for broad MHC coverage across diverse human populations.

Other names
Poliovirus-specific CD4+ T-cell receptorMHC class II-restricted poliovirus TCRPolio-specific TCRPoliovirus-reactive T-cell receptor
02

Mechanism of action

Vaccine-derived poliovirus peptides are processed and presented by MHC class II molecules on antigen-presenting cells to these specific T-cell receptors, inducing CD4+ T-cell activation, cytokine release, and the establishment of immunological memory.

03

Biological functions

Immune responseAntigen recognitionT-cell activationCytokine productionImmunological memory
04

Disease associations

InfectionPoliomyelitis
05

Safety considerations

Cross-reactivity with self-antigens (autoimmunity)Immune evasion via viral antigenic drift or mutationVaccine-associated paralytic poliomyelitis (VAPP) associated with live-attenuated strainsVariable immune response due to MHC polymorphism
06

Interacting drugs

Inactivated poliovirus vaccine (IPV)

1 more in the full profile.

07

Biomarkers

Interferon-gamma (IFN-gamma) productionCD154 (CD40L) expressionMHC class II tetramer bindingCD69 expressionCD25 expression

Beyond the preview

Go deeper on T-cell receptor recognizing poliovirus-derived peptides presented on MHC class II (Poliovirus-specific TCR (MHC-II restricted)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor recognizing poliovirus-derived peptides presented on MHC class II (Poliovirus-specific TCR (MHC-II restricted)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call